Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP464339.RAZLObfTk7GFUOwSVC8GQkPI8AhkxSp4VT-pFNhS1ZN_E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP464339.RAZLObfTk7GFUOwSVC8GQkPI8AhkxSp4VT-pFNhS1ZN_E130_assertion type Assertion NP464339.RAZLObfTk7GFUOwSVC8GQkPI8AhkxSp4VT-pFNhS1ZN_E130_head.
- NP464339.RAZLObfTk7GFUOwSVC8GQkPI8AhkxSp4VT-pFNhS1ZN_E130_assertion wasGeneratedBy ECO_0000203 NP464339.RAZLObfTk7GFUOwSVC8GQkPI8AhkxSp4VT-pFNhS1ZN_E130_provenance.
- NP464339.RAZLObfTk7GFUOwSVC8GQkPI8AhkxSp4VT-pFNhS1ZN_E130_assertion wasDerivedFrom befree-20150227 NP464339.RAZLObfTk7GFUOwSVC8GQkPI8AhkxSp4VT-pFNhS1ZN_E130_provenance.
- NP464339.RAZLObfTk7GFUOwSVC8GQkPI8AhkxSp4VT-pFNhS1ZN_E130_assertion SIO_000772 16949064 NP464339.RAZLObfTk7GFUOwSVC8GQkPI8AhkxSp4VT-pFNhS1ZN_E130_provenance.
- NP464339.RAZLObfTk7GFUOwSVC8GQkPI8AhkxSp4VT-pFNhS1ZN_E130_assertion evidence source_evidence_literature NP464339.RAZLObfTk7GFUOwSVC8GQkPI8AhkxSp4VT-pFNhS1ZN_E130_provenance.
- NP464339.RAZLObfTk7GFUOwSVC8GQkPI8AhkxSp4VT-pFNhS1ZN_E130_assertion description "[The no observed adverse effect level (NOAEL) for chromosome aberrations and HPRT mutations was 1.794 mg/m(3) (0.812 ppm)--the mean exposure level for the highest exposed worker group in this initial study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP464339.RAZLObfTk7GFUOwSVC8GQkPI8AhkxSp4VT-pFNhS1ZN_E130_provenance.